Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

‘Knockout’ technique tested successfully on mice

27.06.2007
No more choking and burning eyes? Hebrew University Ph.D. Student develops new approach to eliminating allergies, asthma

Allergies, like the common cold and asthma, have basically defied the best efforts of modern medicine to cure them. Now, a doctoral candidate at the Hebrew University of Jerusalem School of Pharmacy has come up with a new approach that offers hope for getting rid of them.

For his efforts, Chilean-born Ido Bachelet, a first cousin of the president of Chile, Michelle Bachelet, and a Ph.D. student under the supervision of Prof. Francesca Levi-Schaffer, has been named the winner of one of this year’s Barenholz Prizes for Creativity and Originality in Applied Research. The award, named for its donor, Yehezkel Barenholz, the Dr. Daniel G. Miller Professor of Cancer Research at the Hebrew University-Hadassah Medical School, was presented recently during the Hebrew University Board of Governors 70th meeting.

Bachelet’s research has focused on mechanisms that regulate the function of mast cells – the “villains” in triggering allergic reactions. When exposed to allergens, mast cells react violently and release an enormous array of pro-inflammatory substances, of which histamine is a well known example. These substances lead to acute symptoms ranging from stuffy nose, rash, and airway constriction to the lethal shock known from food or venom allergies. Later on, they attract inflammatory cells that will maintain the response, which often persists as a chronic disease.

Although allergies are usually not perceived as lethal, reality is different. In 2005, over 250,000 people died from asthma worldwide. The World Health Organization estimates that this rate will increase by 20 percent within the next decade if urgent action is not taken. Asthma is the most common chronic disease among children.

Bachelet has identified a receptor protein on mast cells, termed CD300a. This receptor has a prominent negative effect on mast cell activity, virtually shutting down the cell from unleashing allergic responses. Unfortunately, CD300a is widely found throughout the immune system, and simply targeting it could result in undesired, overall immune suppression with serious consequences, as can happen with steroids.

In order to overcome this problem, Bachelet and his research colleague, Ariel Munitz, have designed a small, synthetic, antibody fragment that has the unusual ability of recognizing two targets simultaneously -- the receptor CD300a and a mast cell-specific marker. Thus, the antibody targets CD300a only on the surface of mast cells, avoiding suppression of other immune cells. This antibody potently eliminated four different types of allergic diseases in mice. Moreover, when mice suffering from severe chronic asthma received the antibody in nose drops, they completely reverted to normal, healthy mice in less than two months.

This pioneering project, termed RECEPTRA, presents a novel therapeutic strategy for acute and chronic allergic diseases, and is currently being licensed through Yissum, the Hebrew University’s technology transfer company, to pharmaceutical companies for further development and eventual clinical trials.

Based on its enormous potential, Bachelet and his team predict that with further development, their technology will become the first line of allergy therapy in the near future.

For further information:
Jerry Barach,
Dept. of Media Relations,
the Hebrew University,
Tel: 02-588-2904, or
Orit Sulitzeanu,
Hebrew University spokesperson,
Tel: 02-5882910 or 052-260-8016.

Jerry Barach | The Hebrew University of Jerusal
Further information:
http://media.huji.ac.il

More articles from Health and Medicine:

nachricht Correct connections are crucial
26.06.2017 | Charité - Universitätsmedizin Berlin

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Study shines light on brain cells that coordinate movement

26.06.2017 | Life Sciences

Smooth propagation of spin waves using gold

26.06.2017 | Physics and Astronomy

Switchable DNA mini-machines store information

26.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>